LLY

877.96

-2.32%↓

JNJ

240.27

+0.43%↑

ABBV

209.68

-0.75%↓

NVS

148.25

-0.86%↓

MRK

119.68

+0.62%↑

LLY

877.96

-2.32%↓

JNJ

240.27

+0.43%↑

ABBV

209.68

-0.75%↓

NVS

148.25

-0.86%↓

MRK

119.68

+0.62%↑

LLY

877.96

-2.32%↓

JNJ

240.27

+0.43%↑

ABBV

209.68

-0.75%↓

NVS

148.25

-0.86%↓

MRK

119.68

+0.62%↑

LLY

877.96

-2.32%↓

JNJ

240.27

+0.43%↑

ABBV

209.68

-0.75%↓

NVS

148.25

-0.86%↓

MRK

119.68

+0.62%↑

LLY

877.96

-2.32%↓

JNJ

240.27

+0.43%↑

ABBV

209.68

-0.75%↓

NVS

148.25

-0.86%↓

MRK

119.68

+0.62%↑

Search

Perrigo Co PLC

Cerrado

SectorSanidad

9.52 1.17

Resumen

Variación precio

24h

Actual

Mínimo

9.39

Máximo

9.63

Métricas clave

By Trading Economics

Ingresos

-1.4B

-1.4B

Ventas

66M

1.1B

BPA

0.77

Rentabilidad por dividendo

12.54

Margen de beneficios

-127.478

Empleados

8,100

EBITDA

-1.4B

-1.2B

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+70.58% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

12.54%

2.52%

Próximas Ganancias

6 may 2026

Fecha Próximo Dividendo

16 jun 2026

Próxima Fecha de Ex Dividendo

29 may 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-685M

1.3B

Apertura anterior

8.35

Cierre anterior

9.52

Noticias sobre sentimiento de mercado

By Acuity

19%

81%

41 / 349 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

Perrigo Co PLC Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

14 jul 2025, 13:01 UTC

Adquisiciones, fusiones, absorciones

Perrigo to Sell Dermacosmetics Business to KKR With Focus on Streamlining Company

14 jul 2025, 12:33 UTC

Adquisiciones, fusiones, absorciones

Perrigo: Business Generated About 5% of 2024 Adjusted Operating Income >PRGO

14 jul 2025, 12:33 UTC

Adquisiciones, fusiones, absorciones

Perrigo: Dermacosmetics Branded Business Generated About EUR125 Million Sales in 2024 >PRGO

14 jul 2025, 12:32 UTC

Adquisiciones, fusiones, absorciones

Perrigo: Deal Proceeds to Further Strengthen Balance Sheet >PRGO

14 jul 2025, 12:31 UTC

Adquisiciones, fusiones, absorciones

Perrigo: Deal Includes EUR300 Million Upfront Cash, Up to EUR27 Million Contingent Payments >PRGO

14 jul 2025, 12:31 UTC

Adquisiciones, fusiones, absorciones

Perrigo To Sell Dermacosmetics Branded Business to KKR Investment Vehicle >PRGO

14 jul 2025, 12:30 UTC

Adquisiciones, fusiones, absorciones

Perrigo Announces Agreement to Divest Dermacosmetics Business for Up to EUR327 Million

Comparación entre iguales

Cambio de precio

Perrigo Co PLC previsión

Precio Objetivo

By TipRanks

70.58% repunte

Estimación a 12 Meses

Media 16 USD  70.58%

Máximo 17 USD

Mínimo 15 USD

De acuerdo con 2 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Perrigo Co PLC Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

2 ratings

1

Comprar

1

Mantener

0

Vender

Puntuación técnica

By Trading Central

25.22 / 26.85Soporte y Resistencia

Corto Plazo

Strong Bullish Evidence

Medio plazo

Strong Bullish Evidence

Largo Plazo

Bullish Evidence

Sentimiento

By Acuity

41 / 349 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Perrigo Co PLC

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.